Biosimilars for the treatment of patients with psoriasis: A consensus statement from the Biosimilar Working Group of the International Psoriasis CouncilCapsule Summary
Background: As biosimilars have become available in various parts of the world, the International Psoriasis Council has reviewed aspects of their use. Objective: To provide consensus statements from the Biosimilar Working Group about the use of biosimilars in patients with psoriasis. Methods: A semi...
Main Authors: | Arnon D. Cohen, MD, MPH, PhD, Ronald Vender, MD, FRCPC, Luigi Naldi, MD, Robert E. Kalb, MD, Tiago Torres, MD, PhD, Murlidhar Rajagopalan, MD, Joelle van der Walt, PhD, Lluís Puig, MD (Hon), PhD, Helen S. Young, MB ChB, PhD, FRCP |
---|---|
格式: | 文件 |
语言: | English |
出版: |
Elsevier
2020-12-01
|
丛编: | JAAD International |
主题: | |
在线阅读: | http://www.sciencedirect.com/science/article/pii/S2666328720300523 |
相似书籍
-
An Update Review of Biosimilars of Adalimumab in Psoriasis – Bioequivalence and Interchangeability
由: Zhou X, et al.
出版: (2021-07-01) -
Biosimilars
由: Emel Bülbül Başkan
出版: (2022-04-01) -
Biosimilar Agents for Psoriasis Treatment: The Perspective of Portuguese Patients
由: Alexandra Azevedo, et al.
出版: (2018-09-01) -
Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
由: Changkun Li, et al.
出版: (2023-12-01) -
Portuguese Position Paper on the Use of Biosimilars in Psoriasis
由: Tiago Torres, et al.
出版: (2016-09-01)